New York 2025-2026 Regular Session

New York Assembly Bill A09406

Introduced
12/19/25  
Refer
12/19/25  

Caption

Regulates the sale of methamphetamine precursor drugs.

Impact

The proposed law would amend the general business law by adding provisions that dictate how these drugs can be sold and regulated. All business establishments would be required to implement a real-time stop sale system that monitors transactions involving these substances. By demanding that sales information be filed electronically and that customers provide valid identification, the bill aims to create a comprehensive tracking environment that limits the quantity of these drugs purchased to prevent misuse in methamphetamine production. Additionally, the bill's reach extends to preempting local ordinances that might conflict with these state-level regulations, ensuring uniformity in enforcement across New York.

Summary

Bill A09406 aims to regulate the sale of over-the-counter products containing methamphetamine precursor drugs, specifically those that include ephedrine and pseudoephedrine. The bill introduces strict controls on the distribution of these substances by requiring that all sales be logged and reported via a real-time system that connects to state law enforcement. This initiative seeks to combat the illicit manufacturing of methamphetamine by tightening regulations around its necessary precursors, thereby enhancing public safety while minimizing illicit drug activity associated with these compounds.

Contention

Some points of contention regarding Bill A09406 may arise from the enforcement of these sales regulations. Critics may argue that the requirements on businesses to maintain logs and utilize electronic systems could impose burdensome compliance costs, particularly on smaller retailers. Furthermore, the law preempts local regulations, which may lead to tensions between state authorities and local government entities that have developed tailored approaches to managing the sale of these substances. The requirement of valid government-issued identification and the potential penalties for non-compliance introduces additional complexities that might lead to scrutiny from civic groups advocating for business flexibility.

Companion Bills

No companion bills found.

Previously Filed As

NY HB3087

METHAMPHETAMINE PRECURSORS

NY SB1875

METHAMPHETAMINE PRECURSORS

NY SB726

Limits the sale or purchase of certain drugs

NY SB1069

Limits the sale or purchase of certain drugs

NY SB2347

Methamphetamine; revise penalty for simple possession of certain amounts.

NY S09954

Relates to regulating the sale of oral nicotine pouches.

NY S01481

Relates to penalties for the crimes relating to methamphetamine laboratory operations, including criminal possession of methamphetamine manufacturing materials and unlawful manufacture of methamphetamines.

NY A06851

Relates to penalties for the crimes relating to methamphetamine laboratory operations, including criminal possession of methamphetamine manufacturing materials and unlawful manufacture of methamphetamines.

NY HB2415

kratom products; narcotic drugs

NY SF3087

Restrictions placed on the sale of certain over-the-counter allergy medications modifications

Similar Bills

No similar bills found.